AQEC AQE Core ETF
ETF on NYSE (US) · Actively managed · Listing
Most notable sale · L'Oreal SA
L'Oreal SA sold out
Units went from 99,128 to 0 ($8.12M → $0). Was 1.4% of the Mar 31, 2026 portfolio.
Most notable buy · Booking Holdings Inc.
Booking Holdings Inc. raised 27x
Shares went from 1,788 to 49,005 ($7.53M → $8.73M). Now 1.5% of the portfolio. Estimated trade $8.42M.
Largest holding: Johnson & Johnson, raised <1%, 48,413 shares ($12.3M).
| Current positions Top 10 | % of book |
|---|---|
| Johnson & Johnson JNJ $12.3M · +<1% sh | 2.1% |
| Berkshire Hathaway Inc. New BRK-B $11.8M · +<1% sh | 2.1% |
| GSK plc GSK $11.2M · −1% sh | 2.0% |
| General Dynamics Corporation GD $11.2M · +<1% sh | 2.0% |
| RTX Corporation RTX $11.1M · +<1% sh | 1.9% |
| Apple Inc. AAPL $10.8M · −16% sh | 1.9% |
| Novartis AG NVS $10.4M · +<1% sh | 1.8% |
| Roche Holding AG RHHBY $10.3M · +<1% units | 1.8% |
| Coca-Cola Company (The) KO $10.2M · −1% sh | 1.8% |
| eBay Inc. EBAY $10.0M · −8% sh | 1.7% |
Slices are % of holdings value. Changes ("sh" shares, "units" other holdings) are in the quantity held against Mar 31, 2026.
| Sectors | % of holdings value |
|---|---|
| Healthcare | 16.7% |
| Consumer Defensive | 15.8% |
| Financial Services | 14.2% |
| Communication Services | 13.7% |
| Industrials | 13.2% |
| Technology | 11.6% |
| Consumer Cyclical | 6.6% |
| Basic Materials | 1.7% |
| Unclassified | 6.5% |
| Industries | % of holdings value |
|---|---|
| Drug Manufacturers - General | 9.3% |
| Financial Data & Stock Exchanges | 8.8% |
| Internet Content & Information | 8.0% |
| Household & Personal Products | 7.7% |
| Software - Application | 6.2% |
| Aerospace & Defense | 4.7% |
| Medical Devices | 4.4% |
| Other (25) | 44.5% |
| Unclassified | 6.5% |
| Initiations 1 | Value |
|---|---|
| Honeywell Aerospace Inc. HONA 0.8% of portfolio | $4.47M |
| Increases 46 | Change |
|---|---|
| Booking Holdings Inc. BKNG $7.53M → $8.73M | 27x |
| Accenture plc ACN $7.58M → $8.58M | +80% |
| Zoetis Inc. ZTS $8.67M → $8.33M | +58% |
| Zillow Group, Inc. Z $7.24M → $8.36M | +52% |
| Adobe Inc. ADBE $7.42M → $8.87M | +42% |
| Reckitt Benckiser Group PLC RBGLY $7.58M → $8.94M | +22% |
| Gartner, Inc. IT $8.67M → $8.71M | +23% |
| Intercontinental Exchange Inc. ICE $8.22M → $7.91M | +23% |
| Fox Corporation FOX $8.16M → $8.64M | +20% |
| Medtronic plc. MDT $7.77M → $8.31M | +19% |
| Arthur J. Gallagher & Co. AJG $7.88M → $9.47M | +13% |
| Ryan Specialty Holdings, Inc. RYAN $7.71M → $9.75M | +13% |
| Reductions 17 | Change |
|---|---|
| Honeywell International Inc. HON $9.25M → $4.53M | −51% |
| Alphabet Inc. GOOGL $11.1M → $9.85M | −29% |
| Live Nation Entertainment, Inc. LYV $10.0M → $9.83M | −18% |
| Apple Inc. AAPL $11.3M → $10.8M | −16% |
| Corteva, Inc. CTVA $10.6M → $9.83M | −9% |
| eBay Inc. EBAY $8.86M → $10.0M | −8% |
| Microsoft Corporation MSFT $10.3M → $9.92M | −4% |
| Rentokil Initial plc RTO $10.8M → $9.36M | −5% |
| MSCI Inc. MSCI $8.31M → $8.36M | −3% |
| ASML Holding N.V. ASML $3.77M → $5.47M | −4% |
| Airbnb, Inc. ABNB $8.56M → $9.58M | −1% |
| Kenvue Inc. KVUE $8.86M → $9.71M | −1% |
| Terminations 2 | Change |
|---|---|
| L'Oreal SA LRLCY was $8.12M | −100% |
| SAP SE SAP was $6.98M | −100% |
The other 34 increases
Otis Worldwide Corporation (+15%), Abbott Laboratories (+13%), Wolters Kluwer NV (+13%), Thermo Fisher Scientific Inc (+11%), S&P Global Inc. (+5%), TransUnion (+3%), Haleon PLC (+3%), Unilever PLC (+3%), Home Depot, Inc. (The) (+3%), Diageo plc (+2%), Roper Technologies, Inc. (+1%), Novartis AG (+<1%), Johnson & Johnson (+<1%), Berkshire Hathaway Inc. New (+<1%), General Dynamics Corporation (+<1%), RTX Corporation (+<1%), Roche Holding AG (+<1%), Visa Inc. (+<1%), British American Tobacco p.l.c. (+<1%), Bristol-Myers Squibb Company (+<1%) and 14 more
The other 5 reductions
Philip Morris International Inc (−1%), Coca-Cola Company (The) (−1%), Novo Nordisk A/S (−1%), GSK plc (−1%), Starbucks Corporation (−1%)
Source: the fund's quarterly portfolio reports to the SEC, the portfolio of Jun 30, 2026 (Form N-PORT) vs the portfolio of Mar 31, 2026 (Form N-PORT). Percent changes are changes in the quantity held (shares, or units for holdings that are not a listed equity); dollar values are as reported at each period end. Each column is ranked by the estimated dollar size of the trade: a new or closed position at its value, otherwise the change in shares at the position's own period-end price. Where shares and price per share moved by inverse whole multiples (a split), the earlier share count is restated. Cash and money-market lines are in the book and its value but are never counted as trades. Short positions are listed as such, at their (negative) printed value.
Objective
From the prospectus filed Apr 24, 2026.
The AQE Core ETF (the "Fund") seeks long-term capital appreciation.
Principal investment strategies
The Fund is an actively managed exchange-traded fund that seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its net assets in high-quality equity securities that it believes have the potential for long-term growth. A guiding principle of the Fund's investment process is the consideration of each holding as an ownership interest in an underlying business. As such, the Fund seeks to purchase securities when the market price is reasonable relative to the company's total enterprise value. The Adviser's analysis typically will include consideration 3 of fundamental analysis (including a review of a company's balance sheet, historical earnings, valuation, and long-term growth prospects) to estimate intrinsic value and determine suitability for investment. The Fund typically invests in equity securities of both U.S. and non-U.S. companies. While the Fund may invest in securities issued by companies of any market capitalization, it primarily emphasizes large-cap companies that exhibit stable operating histories, strong financial positions, and durable competitive advantages. The Fund maintains a long-term investment horizon and generally takes a low-turnover approach, though it may sell or reduce a position when an issuer exhibits deteriorating fundamentals, diminished management quality, or when the valuation of a security becomes excessive relative to projected earnings. Additionally, the Fund may sell securities to manage overall portfolio risk or to pursue better investment opportunities. Under normal market conditions, the Fund intends to remain fully invested and typically holds only a small portion of its assets in cash or cash equivalents. The Fund will lend portfolio securities to generate additional income through its custodian acting as its securities lending agent. In exchange for lending its portfolio securities, the borrowers provide collateral that is maintained in an amount at least equal to the current market value of the securities loaned, and is marked-to-market daily. Securities lending may represent no more than one-third of the value of the Fund's total assets (including the loan collateral). Any cash collateral received by the Fund in connection with these loans may be invested in a variety of short-term investments, either directly or indirectly through money market funds that comply with Rule 2a-7 under the 1940 Act. Loan collateral (including any investment of the collateral) is not included in the calculation of the percentage limitations described elsewhere in this Prospectus regarding a Fund's investments in particular types of securities. The Fund is classified as "non-diversified" under the Investment Company Act of 1940 (the "1940 Act"), which means that it may invest more of its assets in a smaller number of issuers than "diversified" funds.
Management and Contact
- Adviser
- Arlington Partners, LLC
- Sub-adviser
- Vident Asset Management
- Portfolio managers
-
Kenneth H. Polk, Chief Investment Officer of the Adviser, William A. (Bill) Levant, III, Chief Investment Strategist of the Adviser and Jordan E. Cherry, Investment Director of the Adviser are jointly and primarily responsible for the day-to-day management of the Fund's portfolio and have been portfolio managers of the Fund since its inception in November 2025.
- Phone
- (804) 267-7400
- [email protected]
- Website
- arlingtonassetmanagement.com
Holdings as of Jun 30, 2026
The full portfolio as of the quarter end Jun 30, 2026, from the fund's report to the SEC (Form N-PORT, filed Aug 27, 2026), the newest we have: we do not read a daily file from this fund's website, or the filing is newer. Every line is listed: holdings we could identify link to their page, the rest (bonds, CLOs, loans, derivatives, securities we do not carry) are shown as filed, debt with its coupon and maturity; Shares is the principal amount for debt. Short positions are negative. Change is the share count against the filing of Mar 31, 2026.
65 lines, 60 linked, weights sum to 99.94% · Actively managed (N-CEN)
| Holding | Ticker / identifier | Type | Shares | Change | Weight | Market value |
|---|---|---|---|---|---|---|
| Johnson & Johnson | JNJ US4781601046 | Equity | 48,413 | +140 | 2.14% | $ 12.295M |
| Berkshire Hathaway Inc | BRK-B US0846707026 | Equity | 23,545 | +70 | 2.05% | $ 11.782M |
| GSK PLC | GSK US37733W2044 | Equity | 214,073 | −2,113 | 1.95% | $ 11.222M |
| General Dynamics Corp | GD US3695501086 | Equity | 31,625 | +91 | 1.95% | $ 11.203M |
| RTX Corp | RTX US75513E1010 | Equity | 58,699 | +168 | 1.94% | $ 11.137M |
| Apple Inc | AAPL US0378331005 | Equity | 37,462 | −7,032 | 1.89% | $ 10.84M |
| Novartis AG | NVS US66987V1098 | Equity | 66,614 | +227 | 1.82% | $ 10.44M |
|
Roche Holding AG
|
RHHBY US7711951043 | Equity | 201,457 | +588 | 1.80% | $ 10.345M |
| Coca-Cola Co/The | KO US1912161007 | Equity | 125,631 | −1,396 | 1.78% | $ 10.21M |
| eBay Inc | EBAY US2786421030 | Equity | 89,787 | −7,572 | 1.75% | $ 10.034M |
| Microsoft Corp | MSFT US5949181045 | Equity | 26,590 | −1,248 | 1.73% | $ 9.919M |
| British American Tobacco PLC | BTI US1104481072 | Equity | 159,840 | +462 | 1.72% | $ 9.872M |
| Alphabet Inc | GOOGL US02079K3059 | Equity | 27,575 | −11,046 | 1.72% | $ 9.854M |
| Corteva Inc | CTVA US22052L1044 | Equity | 116,067 | −10,999 | 1.71% | $ 9.83M |
| Live Nation Entertainment Inc | LYV US5380341090 | Equity | 53,657 | −12,166 | 1.71% | $ 9.825M |
| Ryan Specialty Holdings Inc | RYAN US78351F1075 | Equity | 258,188 | +29,691 | 1.70% | $ 9.749M |
| Kenvue Inc | KVUE US49177J1025 | Equity | 507,930 | −5,996 | 1.69% | $ 9.707M |
| Visa Inc | V US92826C8394 | Equity | 28,200 | +84 | 1.68% | $ 9.675M |
| Philip Morris International In | PM US7181721090 | Equity | 53,453 | −631 | 1.68% | $ 9.67M |
| Bristol-Myers Squibb Co | BMY US1101221083 | Equity | 167,640 | +490 | 1.68% | $ 9.659M |
| Novo Nordisk A/S | NVO US6701002056 | Equity | 200,297 | −2,361 | 1.67% | $ 9.602M |
| Airbnb Inc | ABNB US0090661010 | Equity | 66,946 | −805 | 1.67% | $ 9.58M |
| Arthur J Gallagher & Co | AJG US3635761097 | Equity | 41,264 | +4,889 | 1.65% | $ 9.473M |
| Starbucks Corp | SBUX US8552441094 | Equity | 92,367 | −1,074 | 1.64% | $ 9.439M |
| Rentokil Initial PLC | RTO US7601251041 | Equity | 327,108 | −15,821 | 1.63% | $ 9.359M |
| TransUnion | TRU US89400J1079 | Equity | 128,806 | +3,936 | 1.62% | $ 9.292M |
| RELX PLC | RELX US7595301083 | Equity | 289,533 | +840 | 1.60% | $ 9.17M |
|
Universal Music Group NV
|
UNVGY US91377B1098 | Equity | 875,053 | +2,548 | 1.59% | $ 9.136M |
| Aon PLC | AON IE00BLP1HW54 | Equity | 27,335 | +77 | 1.58% | $ 9.067M |
| CH Robinson Worldwide Inc | CHRW US12541W2098 | Equity | 47,906 | +140 | 1.57% | $ 9.023M |
| Procter & Gamble Co/The | PG US7427181091 | Equity | 61,131 | +175 | 1.56% | $ 8.964M |
|
Reckitt Benckiser Group PLC
|
RBGLY US7562553039 | Equity | 682,225 | +125,066 | 1.56% | $ 8.944M |
| Adobe Inc | ADBE US00724F1012 | Equity | 43,276 | +12,734 | 1.54% | $ 8.872M |
| Thermo Fisher Scientific Inc | TMO US8835561023 | Equity | 17,612 | +1,701 | 1.54% | $ 8.83M |
| Booking Holdings Inc | BKNG US09857L1089 | Equity | 49,005 | +47,217 | 1.52% | $ 8.735M |
| Solventum Corp | SOLV US83444M1018 | Equity | 113,049 | +329 | 1.52% | $ 8.722M |
| Gartner Inc | IT US3666511072 | Equity | 67,199 | +12,446 | 1.52% | $ 8.71M |
| Fox Corp | FOX US35137L2043 | Equity | 184,516 | +30,806 | 1.50% | $ 8.643M |
| Unilever PLC | UL US9047678035 | Equity | 143,711 | +4,367 | 1.50% | $ 8.64M |
| Home Depot Inc/The | HD US4370761029 | Equity | 24,455 | +628 | 1.50% | $ 8.625M |
| Accenture PLC | ACN IE00B4BNMY34 | Equity | 68,947 | +30,695 | 1.49% | $ 8.58M |
| Haleon PLC | HLN US4055521003 | Equity | 914,420 | +29,040 | 1.49% | $ 8.532M |
| Abbott Laboratories | ABT US0028241000 | Equity | 93,837 | +10,821 | 1.48% | $ 8.515M |
| PepsiCo Inc | PEP US7134481081 | Equity | 62,840 | +182 | 1.48% | $ 8.509M |
| News Corp | NWSA US65249B1098 | Equity | 341,681 | +994 | 1.48% | $ 8.484M |
| Automatic Data Processing Inc | ADP US0530151036 | Equity | 37,788 | +112 | 1.47% | $ 8.463M |
| Roper Technologies Inc | ROP US7766961061 | Equity | 24,988 | +277 | 1.47% | $ 8.456M |
| MSCI Inc | MSCI US55354G1004 | Equity | 14,936 | −476 | 1.46% | $ 8.365M |
| Zillow Group Inc | Z US98954M2008 | Equity | 265,331 | +90,362 | 1.46% | $ 8.363M |
| Otis Worldwide Corp | OTIS US68902V1070 | Equity | 116,564 | +15,011 | 1.45% | $ 8.346M |
| Zoetis Inc | ZTS US98978V1035 | Equity | 115,987 | +42,660 | 1.45% | $ 8.335M |
| Medtronic PLC | MDT IE00BTN1Y115 | Equity | 106,259 | +16,591 | 1.45% | $ 8.313M |
| Warner Music Group Corp | WMG US9345502036 | Equity | 305,845 | +889 | 1.44% | $ 8.279M |
|
Wolters Kluwer NV
|
WTKWY US9778742059 | Equity | 126,985 | +14,234 | 1.43% | $ 8.217M |
| Diageo PLC | DEO US25243Q2057 | Equity | 101,711 | +1,828 | 1.42% | $ 8.176M |
| Estee Lauder Cos Inc/The | EL US5184391044 | Equity | 103,353 | +301 | 1.42% | $ 8.16M |
| S&P Global Inc | SPGI US78409V1044 | Equity | 19,701 | +972 | 1.40% | $ 8.023M |
| Intercontinental Exchange Inc | ICE US45866F1049 | Equity | 64,247 | +11,999 | 1.38% | $ 7.909M |
| Walt Disney Co/The | DIS US2546871060 | Equity | 80,744 | +238 | 1.35% | $ 7.772M |
| CME Group Inc | CME US12572Q1058 | Equity | 32,566 | +98 | 1.25% | $ 7.192M |
| NVIDIA Corp | NVDA US67066G1040 | Equity | 30,797 | +91 | 1.07% | $ 6.162M |
| ASML Holding NV | ASML USN070592100 | Equity | 2,751 | −104 | 0.95% | $ 5.473M |
| Honeywell International Inc | HON US4385162056 | Equity | 20,216 | −20,711 | 0.79% | $ 4.526M |
| Honeywell Aerospace Inc | HONA US43849R1059 | Equity | 20,216 | new +20,216 | 0.78% | $ 4.469M |
|
First American Treasury Obliga
|
FXFXX US31846V3289 | Money market | 436,171.53 | +97,914.86 | 0.08% | $ 436.172K |
Trades Mar 31, 2026 to Jun 30, 2026
Changes in shares between the fund's two newest published portfolios, cash left out. Value is the change at the line's own price in the newer portfolio.
| Holding | Ticker | Action | Before | After | Change | Value |
|---|---|---|---|---|---|---|
| Booking Holdings Inc | BKNG | Bought | 1,788 | 49,005 | +47,217 | $ 8.416M |
|
L'Oreal SA
|
LRLCY | Closed | 99,128 | — | −99,128 | $ -8.122M |
| SAP SE | SAP | Closed | 40,772 | — | −40,772 | $ -6.981M |
| Honeywell International Inc | HON | Sold | 40,927 | 20,216 | −20,711 | $ -4.637M |
| Honeywell Aerospace Inc | HONA | New | — | 20,216 | +20,216 | $ 4.469M |
| Alphabet Inc | GOOGL | Sold | 38,621 | 27,575 | −11,046 | $ -3.948M |
| Accenture PLC | ACN | Bought | 38,252 | 68,947 | +30,695 | $ 3.82M |
| Zoetis Inc | ZTS | Bought | 73,327 | 115,987 | +42,660 | $ 3.066M |
| Zillow Group Inc | Z | Bought | 174,969 | 265,331 | +90,362 | $ 2.848M |
| Adobe Inc | ADBE | Bought | 30,542 | 43,276 | +12,734 | $ 2.611M |
| Live Nation Entertainment Inc | LYV | Sold | 65,823 | 53,657 | −12,166 | $ -2.228M |
| Apple Inc | AAPL | Sold | 44,494 | 37,462 | −7,032 | $ -2.035M |
|
Reckitt Benckiser Group PLC
|
RBGLY | Bought | 557,159 | 682,225 | +125,066 | $ 1.64M |
| Gartner Inc | IT | Bought | 54,753 | 67,199 | +12,446 | $ 1.613M |
| Intercontinental Exchange Inc | ICE | Bought | 52,248 | 64,247 | +11,999 | $ 1.477M |
| Fox Corp | FOX | Bought | 153,710 | 184,516 | +30,806 | $ 1.443M |
| Medtronic PLC | MDT | Bought | 89,668 | 106,259 | +16,591 | $ 1.298M |
| Arthur J Gallagher & Co | AJG | Bought | 36,375 | 41,264 | +4,889 | $ 1.122M |
| Ryan Specialty Holdings Inc | RYAN | Bought | 228,497 | 258,188 | +29,691 | $ 1.121M |
| Otis Worldwide Corp | OTIS | Bought | 101,553 | 116,564 | +15,011 | $ 1.075M |
| Abbott Laboratories | ABT | Bought | 83,016 | 93,837 | +10,821 | $ 981.898K |
| Corteva Inc | CTVA | Sold | 127,066 | 116,067 | −10,999 | $ -931.505K |
|
Wolters Kluwer NV
|
WTKWY | Bought | 112,751 | 126,985 | +14,234 | $ 921.082K |
| Thermo Fisher Scientific Inc | TMO | Bought | 15,911 | 17,612 | +1,701 | $ 852.813K |
| eBay Inc | EBAY | Sold | 97,359 | 89,787 | −7,572 | $ -846.171K |
| Microsoft Corp | MSFT | Sold | 27,838 | 26,590 | −1,248 | $ -465.529K |
| Rentokil Initial PLC | RTO | Sold | 342,929 | 327,108 | −15,821 | $ -452.639K |
| S&P Global Inc | SPGI | Bought | 18,729 | 19,701 | +972 | $ 395.857K |
| TransUnion | TRU | Bought | 124,870 | 128,806 | +3,936 | $ 283.943K |
| Haleon PLC | HLN | Bought | 885,380 | 914,420 | +29,040 | $ 270.943K |
| MSCI Inc | MSCI | Sold | 15,412 | 14,936 | −476 | $ -266.579K |
| Unilever PLC | UL | Bought | 139,344 | 143,711 | +4,367 | $ 262.544K |
| Home Depot Inc/The | HD | Bought | 23,827 | 24,455 | +628 | $ 221.483K |
| ASML Holding NV | ASML | Sold | 2,855 | 2,751 | −104 | $ -206.902K |
| Diageo PLC | DEO | Bought | 99,883 | 101,711 | +1,828 | $ 146.935K |
| Airbnb Inc | ABNB | Sold | 67,751 | 66,946 | −805 | $ -115.196K |
| Kenvue Inc | KVUE | Sold | 513,926 | 507,930 | −5,996 | $ -114.584K |
| Philip Morris International In | PM | Sold | 54,084 | 53,453 | −631 | $ -114.154K |
| Coca-Cola Co/The | KO | Sold | 127,027 | 125,631 | −1,396 | $ -113.453K |
| Novo Nordisk A/S | NVO | Sold | 202,658 | 200,297 | −2,361 | $ -113.186K |
| GSK PLC | GSK | Sold | 216,186 | 214,073 | −2,113 | $ -110.763K |
| Starbucks Corp | SBUX | Sold | 93,441 | 92,367 | −1,074 | $ -109.752K |
| Roper Technologies Inc | ROP | Bought | 24,711 | 24,988 | +277 | $ 93.734K |
| Novartis AG | NVS | Bought | 66,387 | 66,614 | +227 | $ 35.575K |
| Johnson & Johnson | JNJ | Bought | 48,273 | 48,413 | +140 | $ 35.556K |
| Berkshire Hathaway Inc | BRK-B | Bought | 23,475 | 23,545 | +70 | $ 35.027K |
| General Dynamics Corp | GD | Bought | 31,534 | 31,625 | +91 | $ 32.236K |
| RTX Corp | RTX | Bought | 58,531 | 58,699 | +168 | $ 31.875K |
|
Roche Holding AG
|
RHHBY | Bought | 200,869 | 201,457 | +588 | $ 30.194K |
| Visa Inc | V | Bought | 28,116 | 28,200 | +84 | $ 28.82K |
| British American Tobacco PLC | BTI | Bought | 159,378 | 159,840 | +462 | $ 28.533K |
| Bristol-Myers Squibb Co | BMY | Bought | 167,150 | 167,640 | +490 | $ 28.234K |
| RELX PLC | RELX | Bought | 288,693 | 289,533 | +840 | $ 26.603K |
|
Universal Music Group NV
|
UNVGY | Bought | 872,505 | 875,053 | +2,548 | $ 26.601K |
| CH Robinson Worldwide Inc | CHRW | Bought | 47,766 | 47,906 | +140 | $ 26.368K |
| Procter & Gamble Co/The | PG | Bought | 60,956 | 61,131 | +175 | $ 25.662K |
| Aon PLC | AON | Bought | 27,258 | 27,335 | +77 | $ 25.54K |
| Solventum Corp | SOLV | Bought | 112,720 | 113,049 | +329 | $ 25.382K |
| Automatic Data Processing Inc | ADP | Bought | 37,676 | 37,788 | +112 | $ 25.082K |
| News Corp | NWSA | Bought | 340,687 | 341,681 | +994 | $ 24.681K |
| PepsiCo Inc | PEP | Bought | 62,658 | 62,840 | +182 | $ 24.643K |
| Warner Music Group Corp | WMG | Bought | 304,956 | 305,845 | +889 | $ 24.065K |
| Estee Lauder Cos Inc/The | EL | Bought | 103,052 | 103,353 | +301 | $ 23.764K |
| Walt Disney Co/The | DIS | Bought | 80,506 | 80,744 | +238 | $ 22.908K |
| CME Group Inc | CME | Bought | 32,468 | 32,566 | +98 | $ 21.641K |
| NVIDIA Corp | NVDA | Bought | 30,706 | 30,797 | +91 | $ 18.208K |
Podcast Mentions
Sign up to see podcast mentions and sentiment
Sign Up